For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Cost of revenue | - | 31 | 342 | 253 |
| Research and development | 2,741 | 2,774 | 1,971 | 3,659 |
| Selling, general, and administrative | 2,459 | 2,916 | 2,404 | 3,485 |
| Total cost of revenue and operating expenses | 5,200 | 5,721 | 4,717 | 7,397 |
| Loss from operations | -5,200 | -5,721 | -4,717 | -7,397 |
| Convertible notes fair value adjustment | 1,063 | 3,508 | -1,427 | -190 |
| Warrant liabilities fair value adjustment | 131 | 231 | 141 | -38 |
| Interest expense | 778 | 749 | 720 | 662 |
| Interest income | 107 | 79 | 102 | 164 |
| Other income (expense), net | 70 | 12 | 102 | -46 |
| Total other loss, net | -1,795 | -4,397 | 770 | -316 |
| Net loss | -6,995 | -10,118 | -3,947 | -7,713 |
| Foreign currency translation adjustment | -44 | 4 | -39 | -61 |
| Comprehensive loss | -7,039 | -10,114 | -3,986 | -7,774 |
| Basic EPS | -0.31 | -0.66 | -0.26 | -0.5 |
| Diluted EPS | -0.31 | -0.66 | -0.35 | -0.51 |
| Basic Average Shares | 22,210,459 | 15,381,565 | 15,381,565 | 15,375,521 |
| Diluted Average Shares | 22,210,459 | 15,381,565 | 15,381,565 | 15,375,521 |
Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. (ADGM)